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Abstract
Embedding health technology assessment (HTA) in a fair process has great potential to capture societal 
values relevant to public reimbursement decisions on health technologies. However, the development of such 
processes for priority setting has largely been theoretical. In this paper, we provide further practical lead ways 
on how these processes can be implemented. We first present the misconception about the relation between 
facts and values that is since long misleading the conduct of HTA and underlies the current assessment-
appraisal split. We then argue that HTA should instead be explicitly organized as an ongoing evidence-
informed deliberative process, that facilitates learning among stakeholders. This has important consequences 
for whose values to consider, how to deal with vested interests, how to consider all values in the decision-
making process, and how to communicate decisions. This is in stark contrast to how HTA processes are 
implemented now. It is time to set the stage for HTA as learning.
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Daniels and colleagues have recently called for an expansion of the practice of health technology assessment (HTA), in order to capture societal 
values relevant to public reimbursement decisions of health 
technologies.1 We agree with their suggestion that embedding 
HTA in a fair process has great potential in achieving this, 
in the sense that this allows for the inclusion of stakeholder 
values. We see this an important development in the revision 
of theory and tools for priority setting – by moving away from 
rather technocratic approaches that merely aim to maximize 
health gains, to, instead, interpreting priority setting as a value 
laden political process, in which the use of evidence-informed 
deliberative processes contributes to setting legitimate 
priorities in health.1-3 
Yet, as we see it, the development of such processes for priority 
setting has largely been theoretical. A companion article 
stresses the need for development and implementation of 
evidence-informed deliberative processes.3 In this paper, we 
propose further practical lead ways on how these processes 
can be implemented. We argue that this requires the inclusion 
of stakeholder’s values and expertise, and this can only be 
realized if HTA is explicitly organized as an ongoing learning 
process among stakeholders – to acquire shared knowledge on 
what is valuable about a specific health technology4 and help 
negotiate between vested interests of stakeholders. This is in 
stark contrast to how HTA processes are implemented now. 
We present this misfit, and then proceed by providing practical 
lead ways on how HTA as learning can be implemented. We 
argue that these processes of learning about the facts and 
values of priority setting need to be proactively coordinated.5,6 
This is how we believe that HTA can best contribute to setting 
fair and legitimate priorities in health.
The Misconception About Facts and Values
It is widely acknowledged that present HTA processes fall 
short to provide decision-makers with a comprehensive 
set of information to base their decisions on.1,7-9 Especially, 
HTA processes do not provide decision-makers with proper 
guidance on how they should judge ethical issues. With 
others, we argue that an important reason is the conduct of 
HTA in two separate phases: (i) the generation of evidence 
itself, or the assessment phase and (ii) the interpretation of 
the evidence collected, or the appraisal phase.10 The mistaken 
underlying belief is that the assessment phase is a value-
free kind of scientific research – which produces objective 
data for the appraisal phase, during which then values are 
brought to bear on the available evidence. This distinction is 
utterly misconceived, since it assumes we can collect facts in 
a value-free and completely objective way.10 In reality, value-
based choices are already made at the point of choosing what 
evidence needs to be collected.
HTA agencies that have institutionalized this separation often 
choose to use a standard set of criteria during the assessment 
phase, pushing the consideration of other criteria into the 
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In a recent contribution to the ongoing debate about the role of power in global health, Gorik Ooms emphasizes the normative underpinnings of global health politics. 
He identifies three related problems: (1) a lack of agreement 
among global health scholars about their normative premises, 
(2) a lack of agreement between global health scholars and 
policy-makers regarding the normative premises underlying 
policy, and (3) a lack of willingness among scholars to 
clearly state their normative premises and assumptions. This 
confusion is for Ooms one of the explanations “why global 
health’s policy-makers are not implementing the knowledge 
generated by global health’s empirical scholars.” He calls 
for greater unity between scholars and between scholars 
and policy-makers, concerning the underlying normative 
premises and grea r open ess when it comes to advocacy.1
We commend the effort to reinstate power a d politics in 
global health and agree that “a purely empirical evidence-based 
approach is a fiction,” and that such a view risks covering up 
“the role of politics and power.” But by contrasting this fiction 
with global health research “driven by crises, hot issues, and 
the concerns of organized interest groups,” as a “path we are 
trying to move away from,” Ooms is submitting to a liberal 
conception of politics he implicitly criticizes the outcomes 
of.1 A liberal view of politics evades the constituting role of 
conflicts and reduces it to either a rationalistic, economic 
calculation, or an individual question of moral norms. This 
is echoed in Ooms when he states that “it is not possible to 
discuss the politics of global health without discussing the 
normative premises behind the politics.”1 But w at if we 
take the political as the primary level and the normative as 
secondary, or derived from the politic l?
That is what we will try to do here, by introducing an 
alternative conceptualization of the political and hence free 
us from the “false dilemma” Ooms also wants to escape. 
“Although constructivists have emphasized how underlying 
normative structures constitute actors’ identities and 
interests, they have rarely treated these normative structures 
themselves as defined and infused by power, or emphasized 
how constitutive effects also are expressions of power.”2 This 
is the starting point for the political theorist Chantal Mouffe, 
and her response is to develop an ontological conception of 
the political, where “the political belongs to our ontological 
condition.”3 Acc rding to Mouffe, society is instituted 
through conflict. “[B]y ‘the political’ I mean the dimensi n of
antagonism which I take t  be constitutive of human societies,
while by ‘politics’ I mean the set of practices and instit tions 
through which an order is created, organizing human 
coexistence in the context of conflictuality provided by the 
political.”3 An issue or a topic needs to be contested to become 
political, and such a contestation concerns public action and 
creates a ‘we’ and ‘they’ form of collective identification. But 
the fixation of social relations is partial and precarious, since 
antagonism is an ever present possibility. To politicize an issue 
and be able to mobilize support, one needs to represent the 
world in a conflictual manner “with opposed camps with 
which people can identify.”3 
Ooms uses the case of “increasing international aid spending 
o  AIDS treatment” to illustrate his point.1 He frames the 
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appraisal phase. The consequence is that the evaluation of 
further concerns – which are not automatically covered by 
the standard criteria – becomes a post-assessment assessment 
exercise. Evidence on these aspects will not be collected or it 
will not be in time for use in the decision-making process.
A demonstration of the misconception about the relation 
between facts and values is the prominent use of cost-
effectiveness analysis (CEA) as a method of evaluation in HTA. 
There is little explicit recognition that the choice to conduct 
a CEA is already dependent on valuing health maximization 
in the first place and that it does not adequately reflect all 
relevant societal values. Worse yet, many of the ‘objective’ 
criteria that HTA relies on in its assessment phase, depend 
to a large extent on the way they work out in operational 
practice.11
Organizing Health Technology Assessment as a Learning 
Process
Organizing ‘HTA as learning’4,10-13 instead requires that 
well-organized deliberative processes and procedures are 
established that induce and help stakeholders spell-out what 
they find relevant values at the very start of the decision-
making process. Also, it is key that stakeholders reflect upon 
evidence whenever it is, or becomes, available – they need 
to ask themselves what the evidence means to them in their 
current practices and what new questions are relevant to 
answer. This includes a deliberation on initial constraints and 
conditions that may hinder the approval of the technology, 
and whether and how these can be overcome so that a positive 
or provisional decision comes within the realm of politically 
legitimated conditions.6,14 This appraisal among all public and 
private stakeholders must continue throughout the process, 
until the end, when politically authorized decision-makers 
have to reach a final (or provisional) decision. As such, 
the process must not be organized as a two-phase process 
– separating assessment and appraisal. Instead, it should 
be organized as a continuous interactive and dialectical 
exploration of what is valuable (or what gives stakeholders 
reason for concern) about the health technology at stake. 
The underlying assumption is that stakeholders’ understanding 
of the technology, the disease or its further context may 
change, or evolve, when stakeholders participate in a learning 
process among stakeholders. This requires from stakeholders 
that they are both able and willing to learn, and experimental 
and anecdotal evidence supports this.15-18 Also, it is assumed 
that such new understanding is an improvement, compared 
to the initial understanding of stakeholders, and that 
decision-making based on this new understanding is better 
able to provide both stakeholders and citizens outside the 
process with well-justified reasons to confer legitimacy to the 
decision-making process and its final decision. 
Whose Values Are Important?
In order to identify all relevant values, knowledge and 
questions, all stakeholders who are somehow affected by 
the to-be-made decision should be able to participate in 
the process – either indirectly represented via appraisal 
committees, interest groups, organizations, or directly as 
patients, healthcare workers or citizens (taxpayers). If not all 
stakeholders are involved, potentially valuable insights are 
easily missed out on – hindering the learning process.
In particular, there is a strong normative demand to provide 
people who are adversely affected by priority setting decisions 
with well-justified reasons for conferring legitimacy to 
the decision.19 This implies that HTA processes that aim 
to optimize priority setting decisions – with the aim of 
increasing the fairness and legitimacy of these processes – 
should be organized in such a way that special attention is 
given to consult those who are adversely affected by decisions 
each time a tentative decision is reached. This specific 
(conflict) interaction can at the same time be an important 
driver for learning and produce relevant questions for further 
assessment.
Are Public Values the Sum of Private Values?
Stakeholders often have strong vested interests and it should 
not come as a surprise that they initially push in favour of 
these interests. This has two consequences. Firstly, in practice, 
unregulated discussions and unorganized deliberative 
processes easily end up in unending disputes. Especially 
so, when stakeholders are only involved at the end of the 
decision-making process, during the appraisal phase –
giving stakeholders the impression there are only limited 
opportunities left to have an impact on decision-making and 
offering them little time to learn from other perspectives 
and arguments. This again indicates the need to regulate 
deliberative processes, and involve all stakeholders right from 
the start. Such regulation should clarify how stakeholders can 
contribute to the process, rules of argumentation, weighing, 
trading-off arguments and should make explicit how the final 
decision is to be taken. 
Second, stakeholder consultation in the presence of vested 
interests likely captures private values, but it is less able to 
capture specific public interests that we have good reasons to 
care about, such as safeguarding equal access to good quality 
healthcare, efficiency and cost containment. Such public 
interests are not per se endorsed or defended as important 
by (private) stakeholders. Therefore, if we agree on the 
importance of specific public interests, that are the product 
of (inter)national learning about what should count as 
legitimate public interests, their consideration and inclusion 
into the learning process must be organized – in a legitimate 
way. This may translate eg, into a mandatory consideration 
of criteria that reflect broad societal interest and consensus, 
like effectiveness, cost-effectiveness or severity of disease. 
Or, in countries where mandatory consideration of criteria is 
not pursued (or where they lack consensus on criteria that 
reflect broad societal interest) there is potential to learn from 
internationally endorsed societal values, that are the result of 
international and academic learning. 
How to Consider All Values in the Decision-Making Process?
When relevant values or key questions are identified 
throughout the process, they likely require further assessment. 
This may take the shape of (systematically) reviewing the 
literature, or creating an evidence-base for values that are 
quantifiable – eg, if health maximization is valued, then the 
technology’s performance can be assessed quantitatively by 
means of CEA, or for severity of disease by calculating the 
associated proportional shortfall.20 Values that are more 
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difficult to quantify may be subjected to qualitative analysis, 
ie, ethical analysis or (expert) stakeholder opinions, to the 
extent possible. In the decision-making process, these pieces 
of quantitative and qualitative evidence – in conjunction with 
other values – should be deliberated on. The focus should be 
on finding out how these different pieces of information relate 
to each other and includes the making of value judgments 
about the available information. Again, this implies that 
appraisal and assessment go hand in hand throughout the 
process – constantly building and progressing towards a 
coherent and legitimate decision – and are not organized as 
separate phases. In a democratic society, political accountable 
decision-maker(s) hold the final authorizing decision-making 
power and therefore, stay accountable, not only for taking the 
final (or provisional) decision, but also for the deliberative 
procedures and actions that have been undertaken to come 
to this decision. However, this then warrants clarification on 
how responsible public decision-makers proceed from being 
one of the stakeholders – representing their own (public) 
interests – to taking the final decision in a fair way. How to 
best achieve this is yet unclear. 
How to Communicate the Argumentation – and Learning 
– That Led to the Final Decision? 
It is important that all argumentation – on the use (or rejection) 
of criteria and their importance – is documented and made 
explicit in documents that serve to explain the decision to 
those who did not participate themselves. It is essential that 
not only the final result and its main rationales are spelled-
out, but explanations why other identified concerns were 
not included should also be made explicit. Doing so in 
accountable ways will increase the likelihood that citizens 
who did not participate – and did not go through a learning 
process – can follow the complete reasoning underlying to the 
final decision. This allows for vicarious learning,4 and makes 
it more likely that they confer legitimacy to the process – and 
consider the decision as fair and legitimate – for well-justified 
reasons. Also, it may prevent that involved stakeholders shy 
away from making well-justified compromises that they would 
otherwise feel burdened to communicate in a convincing way 
to the ones they represent.
Current Deliberative Approaches
A number of approaches for priority setting concentrate on 
evidence-informed deliberative processes, including the 
accountability for reasonableness (A4R),2,21 multi-criteria 
decision analysis (MCDA)22 and programme budgeting and 
marginal analysis (PBMA) frameworks.23,24 All consider 
deliberative processes important to develop and interpret 
the evidence-base for decision-making on the basis of 
stakeholder values and interests and to a certain extent 
foster learning among stakeholders. Interactive technology 
assessment (iTA)12,13 is specifically tailored to the concept of 
‘HTA as learning’ and deliberative decision-making and is 
currently only in its experimental stage. Other approaches 
include citizen juries25 or round table conferences where 
stakeholders (eg, medical professionals, healthcare providers, 
health purchasers) are induced to reflect upon the technology 
at stake.18 We see large potential in the integration of such 
approaches to support evidence-informed deliberation and 
learning among stakeholders.
As an example, we have recently operationalized, implemented 
and evaluated a new process to guide priority setting in HIV/
AIDS26 in West Java, Indonesia that integrates the A4R and 
MCDA frameworks.27-29 The overall aim of the process was 
to organise priority setting as an interactive learning process. 
A recent evaluation indicated that involved stakeholders 
were overall positive about the process, as it had improved 
the quality of decision-making – especially in terms of 
use of multiple criteria and concrete evidence, the active 
participation of stakeholders, and transparency of decision-
making.27,29
Also, the Dutch National Health Care Institute is now 
introducing a scoping exercise in their decision-making 
process. During this scoping exercise stakeholders are 
consulted to help determine relevant outcome measures 
for the effectiveness of an intervention, which is a first step 
towards overcoming the assessment – appraisal split.14,20 
Furthermore, a recent exploration of the potential role for 
MCDA in the Dutch decision-making process, showed that 
more deliberative forms of MCDA have potential to help 
structure deliberation among stakeholders.15
Research Agenda
We see the following research agenda as key for progressing 
towards evidence-informed deliberative processes in priority 
setting: 
•	 The use of a deliberative fair process is based on the 
assumption that stakeholders learn throughout the 
process and adjust their perspectives on the importance of 
criteria. Research – in the form of case studies – is needed 
that qualifies this assumption and evaluates learning by 
stakeholders and its impact on the final decision. 
•	 Further research is needed on the translation of the 
practical lead ways as identified in this paper into 
organizational processes of HTA agencies. This relates 
to questions as: how can the concept of learning be best 
integrated into already existing deliberative approaches? 
How can processes be organized such that they can 
properly involve stakeholders?30 What kind of skills and 
expertise are needed throughout the process to make 
it a success, eg, interviewing skills to elicit stakeholder’ 
values? And how can this be organized within the 
time limits for decision-making? How can responsible 
decision-makers best guarantee that the final decision is 
taken fairly, considering they themselves are first actively 
participating in deliberation? How can decisions be best 
documented, reported and communicated to the general 
public, eg, with empathy, and in an understandable way? 
To answer these questions, it may be instrumental to 
review institutionalized deliberative processes in other 
sectors in society, eg, law.6
•	 Research has produced several lists of ‘relevant’ criteria 
that decision-makers can use when making a decision.31-33 
Each list claims to capture a basic, generic, core set of 
criteria. Research is needed that identifies whether such 
a default list is useful to decision-makers as a starting 
point for deliberation, and if so, what should be on the 
list and in what form it can be provided to decision-
makers. Eg, do stakeholders need in depth explanations 
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of these criteria, or do they only require a short overview? 
Should the list of criteria be accompanied by an overview 
of arguments in favor or against trading-off specific 
criteria, to help stakeholders deliberate and form their 
judgements on the relative importance of criteria? Do the 
information needs differ per stakeholder group?
•	 Research is needed on how the use of evidence-informed 
deliberative processes relates to the currently dominant 
theoretical welfare framework on priority setting. Eg, does 
the use of such processes lead to welfare maximization in 
the same sense?
The Bigger Picture: Health Technology Assessment as 
Social Learning
Presently, HTA is focused on providing a solution to the 
temporary task in front of us, namely, the priority setting 
exercise for which a decision has to be made. However, 
if efforts are made to organize HTA processes such that 
they truly enable learning among stakeholders and help 
shape understanding, then the impact of HTA will reach 
beyond the specific decision at hand – helping us to refine 
our societal understanding of what is valuable about health 
technologies and health. As such, it can actually stimulate 
social debate – which is valuable in itself. Learning from 
stakeholders (including citizens) is also instrumental in the 
sense that their expertise may help decision-makers to alter 
the limiting conditions and constraints in such ways that 
(provisional) approval becomes in the realm of possibilities.6 
Then, HTA will be instrumental to discovering means to push 
out the boundaries of the possible, creating access to health 
technologies that are judged valuable but would otherwise 
have remained unavailable.
In conclusion, if we truly want to establish fair processes for 
priority setting that take into account all relevant social values, 
then we must re-organize the HTA process as an ongoing 
learning process – by soliciting stakeholders’ values and 
expertise right from the start, organize evidence collection on 
the basis of these values, and allow an organized interactive 
dialogue between stakeholders on the need for additional 
evidence and its meaning throughout the process. It is time to 
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